Clinical trial
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
NCT06409585 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
- Lead sponsor
- University of Edinburgh
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 1, 2023
- Completion date
- January 1, 2028
- Enrollment
- 290 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmogenic right ventricular cardiomyopathy 1, cardiac sarcoidosis, heart failure with preserved ejection fraction, hypertensive heart disease, hypertrophic cardiomyopathy, myocarditis, tako tsubo cardiomyopathy